Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).
Pakistani police say they have arrested the key suspect in the gang rape of a woman polio worker who was assaulted by three ...
A Chinese aircraft carrier entered Japan’s contiguous waters for the first time on Wednesday, leading Tokyo to convey its ...
Bristol Myers Squibb today announced new data from the Phase 3 DAYBREAK trial demonstrating that decreased rates of brain volume loss were sustained in the open-label extension (OLE) for patients ...
Avelumab is under clinical development by Merck and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II drugs for Cervical Cancer have a 35% phase transition success rate ...
The FDA greenlighted a new vaccine for Mpox ... NCNA closed Friday's trading at $3.66, down 52.65%. Merck (MRK), on Thursday, announced it is discontinuing two phase III trials of its blockbuster ...
2 COVID-19 variant—JN.1 is the parent variant of KP.2. The FDA in June asked vaccine makers to create shots that target the coronavirus’ JN.1 variant, but later changed this recommendation to ...
The Meningioma drugs in development market research report provides comprehensive information on the therapeutics under development for Meningioma, complete with analysis by stage of development, drug ...
REUTERS/Andrew Kelly Aug 29 (Reuters) – The U.S. Food and Drug Administration (FDA) has approved expanded use of Emergent BioSolutions’ EBS.N ACAM2000 smallpox vaccine to include people at ...
SAVANNAH, Ga. (WTOC) - Amid a summer surge in COVID as the CDC reports an 18% increase in people testing positive across the US compared to this week last year, the FDA approving a new vaccine. WTOC ...
*For related coverage, watch above. WASHINGTON (AP) — U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully ...
Back in June, the FDA advised drug manufacturers to change the vaccine formula to better protect against currently circulating variants. “There shouldn’t be a big production problem because we ...
